Clinical Trial

The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This clinical trial is designed as a single - arm, open - label, single - center, investigator - initiated early - phase clinical study. The primary objective is to evaluate the safety of UTAA91 injection in treating subjects with refractory moderate - to - severe active rheumatoid arthritis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-25.
Status change: Not Yet Recruiting → Recruiting 2025-07-15
Trial Details
NCT Number NCT07001956
Lead Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions Rheumatoid Arthritis (RA)
Enrollment 24 participants
Start Date 2025-05-30
Primary Completion 2027-12 (estimated)
Study Completion 2040-06 (estimated)
Updated on ClinicalTrials.gov 2025-07-18